Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions

Update Il y a 4 ans
Reference: NCT01179659

Woman and Man

  • | Country :
  • Canada
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of this study was to assess the single-dose bioequivalence of KUDCO's and Wyeth Pharmaceuticals' (Protonix) 40 mg pantoprazole sodium delayed-lease tablets, under fed conditions.


Inclusion criteria

  • Healthy

Links